IL-5 promotes the expansion and survival of antigen specific T regulatory cells (Treg) (38), and treatment with recombinant IL-5 leads to an expansion of Treg and reduces pathology in experimental autoimmunity (39). Here, IL5 is linked to Autoimmunity.